Procter & Gamble Health Limited share price
NSE: PGHL · ISIN INE199A01012
Key numbers
- Market cap
- ₹ 8,974 Cr
- Current price
- ₹ 5,406.00
- 52-week high / low
- ₹ 6,975 / 4,707
- Stock P/E
- 25.2
- Book value
- ₹ 316.0
- Dividend yield
- 2.87%
- ROCE
- 83.3%
- ROE
- 61.5%
- Debt to equity
- 0.02
- Sales growth (3 yrs)
- 8.2%
- Profit growth (3 yrs)
- 19.3%
- 1-year return
- -13.5%
About Procter & Gamble Health Limited
Procter & Gamble Health Limited manufactures and markets pharmaceutical and chemical products in India and internationally. It offers over-the-counter products, vitamins, minerals, and supplements under the Betamil, Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen brand names. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. The company operates as a subsidiary of Procter & Gamble Overseas India B.V.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 339 | 325 | 374 | 370 | 364 |
| Operating profit | 90 | 120 | 110 | 136 | 100 |
| Net profit | 66 | 89 | 78 | 95 | 96 |
| EPS (₹) | 39.87 | 53.54 | 46.74 | 56.99 | 57.92 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.